By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

TiGenix 

Head Office
Technologielaan 3
Leuven    B - 3001  Belgium
Phone: 32-16-39-60-60 Fax: 32-16-39-60-70


SEARCH JOBS


Industry
Biotechnology






Company News
TiGenix Announces Six-Month Phase I/II Results Of Allocsc-01 In Acute Myocardial Infarction 6/20/2016 11:30:00 AM
TiGenix CEO Eduardo Bravo Assumes Leadership Of European Biopharmaceutical Enterprises (EBE) 6/17/2016 8:54:52 AM
TiGenix CEO Eduardo Bravo Assumes Leadership Of European Biopharmaceutical Enterprises (EBE) 6/16/2016 10:54:31 AM
TiGenix Release: Convening Notice To The Annual Shareholders' Meeting To Be Held On 2 June 2016 5/3/2016 8:40:54 AM
TiGenix Selects TFS For The First Clinical Trial To Treat Severe Sepsis With Allogeneic Expanded Adipose-Derived Stem Cells 4/19/2016 9:06:33 AM
TiGenix Presents 24 Week Results Of Its Cx601 Phase III Trial At ECCO 2016 3/18/2016 9:03:35 AM
TiGenix Announces Positive 52-Week Phase III Results Of Cx601 In Complex Perianal Fistulas In Crohn's Disease Patients 3/7/2016 12:38:25 PM
TiGenix Submits MAA To European Medicines Agency For Cx601 For The Treatment Of Complex Perianal Fistulas In Crohn's Disease Patients 3/2/2016 3:49:25 PM
TiGenix Obtains Commercial Production License For Cx601 2/23/2016 9:17:58 AM
TiGenix Announces Acceptance Of Cx601 Abstract For Presentation At ECCO 2016 Congress 1/11/2016 9:28:39 AM
12345678910...
//-->